NANHUA FUTURES (02691) spent approximately HKD 1.1731 million on September 7 to repurchase 170,000 shares.
Nanhua Futures Co., Ltd. (02691) announced that on September 7, 2026, the company spent approximately HKD 1.1731 million to repurchase 170,000 shares, with a repurchase price ranging from HKD 6.835 to 6.91 per share.
NANHUA FUTURES (02691) announced that on September 7, 2026, the company spent approximately HKD 1.1731 million to buy back 170,000 shares, at a repurchase price of HKD 6.835 to 6.91 per share.
Related Articles
YOUZAN (06051) spent HKD 1.0693 million to repurchase 900,000 shares on September 7.
Jiangsu Hengrui Pharmaceuticals (01276) has received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for HRS-6209 capsules and HRS-4508 tablets.
PW MEDTECH (01358) spent approximately HKD 74,700 to repurchase 78,000 shares on September 7.
YOUZAN (06051) spent HKD 1.0693 million to repurchase 900,000 shares on September 7.
Jiangsu Hengrui Pharmaceuticals (01276) has received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration for HRS-6209 capsules and HRS-4508 tablets.
PW MEDTECH (01358) spent approximately HKD 74,700 to repurchase 78,000 shares on September 7.
RECOMMEND
